Abstract

There are widespread international medical studies showing rising infections after prostate biopsy, corresponding to increases in antimicrobial resistance, particularly fluoroquinolones (FQs). 1 Batura D. Rao G.G. The national burden of infections after prostate biopsy in England and Wales: a wake-up call for better prevention. J Antimicrob Chemother. 2013; 68: 247-249 Crossref PubMed Scopus (57) Google Scholar , 2 Loeb S. van den Heuvel S. Zhu X. et al. Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol. 2012; 61: 1110-1114 Abstract Full Text Full Text PDF PubMed Scopus (227) Google Scholar There are many ways to tackle this problem, which include more selective screening and biopsy, changing the biopsy technique, or improving infectious prophylaxis, or both. Screening Rectal Culture to Identify Fluoroquinolone-resistant Organisms Before Transrectal Prostate Biopsy: Do the Culture Results Between Office Visit and Biopsy Correlate?UrologyVol. 82Issue 1PreviewTo investigate the performance of screening rectal cultures obtained 2 weeks before transrectal prostate biopsy to detect fluoroquinolone-resistant organisms and again at transrectal prostate biopsy. Full-Text PDF ReplyUrologyVol. 82Issue 1PreviewWe would like to thank the author of the editorial comment for the thorough review of our manuscript and for highlighting techniques to counter the current rise in prostate biopsy infections. Additionally, the rise in active surveillance will assuredly lead more patients “at risk” who have previous fluoroquinolone (FQ) exposure from past biopsies. In addition to improving patient selection and accuracy of prostate biopsies, a paradigm shift is needed regarding antimicrobial prophylaxis for transrectal prostate biopsy. Full-Text PDF

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.